Dennis J. Selkoe - Jan 3, 2022 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Director
Signature
/s/ Michael J. Malecek, as attorney-in-fact for Dennis J. Selkoe
Stock symbol
PRTA
Transactions as of
Jan 3, 2022
Transactions value $
-$191,083
Form type
4
Date filed
1/5/2022, 08:02 PM
Previous filing
Oct 1, 2021
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTA Ordinary Shares, par value $0.01 per share Options Exercise $46.2K +5K +175.75% $9.23* 7.85K Jan 3, 2022 Direct
transaction PRTA Ordinary Shares, par value $0.01 per share Sale -$99.8K -2.13K -27.19% $46.81 5.71K Jan 3, 2022 Direct F1, F2
transaction PRTA Ordinary Shares, par value $0.01 per share Sale -$113K -2.38K -41.58% $47.60 3.34K Jan 3, 2022 Direct F1, F3
transaction PRTA Ordinary Shares, par value $0.01 per share Sale -$24.3K -492 -14.74% $49.48 2.85K Jan 3, 2022 Direct F1, F4
holding PRTA Ordinary Shares, par value $0.01 per share 1.36K Jan 3, 2022 By wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Options Exercise $0 +5K +500% $0.00 6K Jan 3, 2022 Ordinary Shares 5K $9.23 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $46.30 to $47.26, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The transaction was executed in multiple trades in prices ranging from $47.30 to $48.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The transaction was executed in multiple trades in prices ranging from $49.03 to $49.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.